TheEdgeResearch
Home / Stocks / INSD

Instadose Pharma Corp. (INSD)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$53,193
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
7.00
52-Wk Range
0.0001-0.0001
CEO
Antonio Rocco Franchino
Country
CA
Currency
USD

Instadose Pharma Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Burlington, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $53,193. On trailing twelve-month figures it carries a trailing P/E of -0.02, a net margin of 0.0%. Its beta of 7.00 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.02
Price / Sales
0.00
Price / Book
-0.06
EV / EBITDA
-0.53
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2020-10-27
Headquarters
Burlington, ON, CA
About Instadose Pharma Corp.

Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.

Comparable companies

Instadose Pharma Corp. is most often compared with the following Healthcare names:

ATTBFBIOIFCBGLHENCISOLFLRDSFMHTXNUNZOWCPQEBR
More research on INSD
INSD technical analysis INSD TheEdge Score Compare against peers
Open full interactive analysis & DCF →